Test Price
2,800 AED✅ Home Collection Available
MLPH Gene Griscelli Syndrome Type 3 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary: This advanced NGS-based genetic test analyzes the MLPH gene to confirm or rule out Griscelli syndrome type 3 (GS3), a rare autosomal recessive hypopigmentation disorder. Offering 99.9% diagnostic sensitivity, the test includes ISO-certified processing, premium home phlebotomy via cold-chain logistics, and post-test clinical guidance by a DHA-licensed Consultant Medical Geneticist.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This diagnostic test employs Next-Generation Sequencing (NGS) to achieve comprehensive coverage of the MLPH gene, including all exons and splice sites. It enables precise molecular confirmation of Griscelli syndrome type 3 and differentiation from related disorders such as Chediak–Higashi syndrome.
| Feature | Our Test (MLPH NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene coverage (all exons, splice sites) | Targeted mutation analysis only |
| Methodology | Next-Generation Sequencing (NGS) | Sanger Sequencing (single amplicons) |
| Turnaround | 3–4 Weeks | 6–8 Weeks (by referral labs) |
| Home Collection | Available (Cold-Chain) | Often Not Available |
Physician Insight & Safety Protocols
“Griscelli syndrome type 3 is characterized by isolated cutaneous hypopigmentation without immune or neurological manifestations. Genetic confirmation through MLPH sequencing is essential for accurate genetic counseling and to differentiate from other syndromic hypopigmentation disorders. All results must be interpreted in the context of clinical phenotype and family history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients with active systemic infection, coagulopathy contraindicating venipuncture, or inability to provide informed consent.
- Emergency Red Flags: If the patient exhibits fever, hepatosplenomegaly, or neurological deterioration (suggestive of hemophagocytic lymphohistiocytosis or Griscelli types 1/2), immediate emergency medical evaluation is mandatory—this genetic test is not a substitute for acute care.
- Pediatric/Minor Consent: In compliance with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability, all testing of individuals under 18 requires legal guardian consent and certified genetic counseling.
Medication Advisory
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This test does not require any medication changes.
Patient FAQ & Clinical Guidance
1. What is the MLPH gene test for Griscelli syndrome type 3?
This genetic test detects mutations in the MLPH gene that cause Griscelli syndrome type 3, a disorder characterized by silvery-gray hair and skin depigmentation. It uses NGS technology for high accuracy.
2. How is the test performed and what sample is required?
A peripheral blood sample or DNA on an FTA card is collected at home by a certified phlebotomist. The sample is then analyzed using NGS to identify mutations in the MLPH gene.
3. How long do results take and what is the cost?
Results are typically ready within 3 to 4 weeks. The test is priced at 2,800 AED. Direct insurance billing is available through our WhatsApp support.
4. Can this test be performed on children?
Yes, for minors (under 18), legal guardian consent is required, and certified genetic counseling is provided as per UAE regulations.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Frameworks
- This diagnostic service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for the secure handling of genetic and personal data.
- Full compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields regarding electronic health records and data sharing.
- Genetic testing and patient consent processes are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified (Certificate: INT/EGQ/2509DA/3139), DHA/MOHAP Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | MLPH Gene Griscelli Syndrome Type 3 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E70.39 (Other disorders of tyrosine metabolism) |
| LOINC Code | 93852-3 (MLPH gene mutation analysis) |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians